Is the current approach to reviewing new drugs condemning the victims of rare diseases to death? A call for a national orphan drug review policy.

ABSTRACT:

SUBMITTER: Clarke JT 

PROVIDER: S-EPMC1329458 | biostudies-literature | 2006 Jan

REPOSITORIES: biostudies-literature